JP6317354B2 - 血漿による胎児または腫瘍のメチロームの非侵襲的決定 - Google Patents

血漿による胎児または腫瘍のメチロームの非侵襲的決定 Download PDF

Info

Publication number
JP6317354B2
JP6317354B2 JP2015532250A JP2015532250A JP6317354B2 JP 6317354 B2 JP6317354 B2 JP 6317354B2 JP 2015532250 A JP2015532250 A JP 2015532250A JP 2015532250 A JP2015532250 A JP 2015532250A JP 6317354 B2 JP6317354 B2 JP 6317354B2
Authority
JP
Japan
Prior art keywords
methylation
dna
region
plasma
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2015532250A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015536639A (ja
JP2015536639A5 (enExample
Inventor
ワイ クン チウ ロッサ
ワイ クン チウ ロッサ
クワン チー チャン
クワン チー チャン
ユク−ミン デニス ロー
ユク−ミン デニス ロー
ミウ ファン ルン
ミウ ファン ルン
ペイヨン チャン
ペイヨン チャン
ワイ マン チャン
ワイ マン チャン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chinese University of Hong Kong CUHK
Original Assignee
Chinese University of Hong Kong CUHK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50340462&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP6317354(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US13/842,209 external-priority patent/US9732390B2/en
Application filed by Chinese University of Hong Kong CUHK filed Critical Chinese University of Hong Kong CUHK
Publication of JP2015536639A publication Critical patent/JP2015536639A/ja
Publication of JP2015536639A5 publication Critical patent/JP2015536639A5/ja
Application granted granted Critical
Publication of JP6317354B2 publication Critical patent/JP6317354B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2523/00—Reactions characterised by treatment of reaction samples
    • C12Q2523/10—Characterised by chemical treatment
    • C12Q2523/125—Bisulfite(s)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2535/00—Reactions characterised by the assay type for determining the identity of a nucleotide base or a sequence of oligonucleotides
    • C12Q2535/122—Massive parallel sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
JP2015532250A 2012-09-20 2013-09-20 血漿による胎児または腫瘍のメチロームの非侵襲的決定 Active JP6317354B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201261703512P 2012-09-20 2012-09-20
US61/703,512 2012-09-20
US13/842,209 2013-03-15
US13/842,209 US9732390B2 (en) 2012-09-20 2013-03-15 Non-invasive determination of methylome of fetus or tumor from plasma
US201361830571P 2013-06-03 2013-06-03
US61/830,571 2013-06-03
PCT/AU2013/001088 WO2014043763A1 (en) 2012-09-20 2013-09-20 Non-invasive determination of methylome of fetus or tumor from plasma

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018061744A Division JP6683752B2 (ja) 2012-09-20 2018-03-28 血漿による胎児または腫瘍のメチロームの非侵襲的決定

Publications (3)

Publication Number Publication Date
JP2015536639A JP2015536639A (ja) 2015-12-24
JP2015536639A5 JP2015536639A5 (enExample) 2016-08-25
JP6317354B2 true JP6317354B2 (ja) 2018-04-25

Family

ID=50340462

Family Applications (6)

Application Number Title Priority Date Filing Date
JP2015532250A Active JP6317354B2 (ja) 2012-09-20 2013-09-20 血漿による胎児または腫瘍のメチロームの非侵襲的決定
JP2018061744A Active JP6683752B2 (ja) 2012-09-20 2018-03-28 血漿による胎児または腫瘍のメチロームの非侵襲的決定
JP2020055387A Active JP6985753B2 (ja) 2012-09-20 2020-03-26 血漿による胎児または腫瘍のメチロームの非侵襲的決定
JP2021188060A Pending JP2022031753A (ja) 2012-09-20 2021-11-18 血漿による胎児または腫瘍のメチロームの非侵襲的決定
JP2023167714A Active JP7594817B2 (ja) 2012-09-20 2023-09-28 血漿による胎児または腫瘍のメチロームの非侵襲的決定
JP2024200780A Pending JP2025026936A (ja) 2012-09-20 2024-11-18 血漿による胎児または腫瘍のメチロームの非侵襲的決定

Family Applications After (5)

Application Number Title Priority Date Filing Date
JP2018061744A Active JP6683752B2 (ja) 2012-09-20 2018-03-28 血漿による胎児または腫瘍のメチロームの非侵襲的決定
JP2020055387A Active JP6985753B2 (ja) 2012-09-20 2020-03-26 血漿による胎児または腫瘍のメチロームの非侵襲的決定
JP2021188060A Pending JP2022031753A (ja) 2012-09-20 2021-11-18 血漿による胎児または腫瘍のメチロームの非侵襲的決定
JP2023167714A Active JP7594817B2 (ja) 2012-09-20 2023-09-28 血漿による胎児または腫瘍のメチロームの非侵襲的決定
JP2024200780A Pending JP2025026936A (ja) 2012-09-20 2024-11-18 血漿による胎児または腫瘍のメチロームの非侵襲的決定

Country Status (28)

Country Link
EP (6) EP4056712B1 (enExample)
JP (6) JP6317354B2 (enExample)
KR (5) KR102307424B1 (enExample)
CN (2) CN117757932A (enExample)
AU (5) AU2013317708C1 (enExample)
BR (3) BR122021021825B1 (enExample)
CA (2) CA3122779A1 (enExample)
CY (1) CY1124139T1 (enExample)
DK (4) DK3354747T3 (enExample)
EA (1) EA201500327A1 (enExample)
ES (4) ES2994426T3 (enExample)
FI (2) FI4056712T3 (enExample)
HR (3) HRP20241142T1 (enExample)
HU (3) HUE053822T2 (enExample)
IL (4) IL299444B2 (enExample)
LT (2) LT4056712T (enExample)
MX (1) MX360034B (enExample)
MY (2) MY173356A (enExample)
NZ (2) NZ706269A (enExample)
PH (2) PH12015500547B1 (enExample)
PL (4) PL3354747T3 (enExample)
PT (4) PT2898100T (enExample)
SG (2) SG10201705198UA (enExample)
SI (1) SI4056712T1 (enExample)
SM (1) SMT202100256T1 (enExample)
TW (5) TWI806621B (enExample)
WO (1) WO2014043763A1 (enExample)
ZA (1) ZA201501772B (enExample)

Families Citing this family (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101153336B (zh) 2006-09-27 2011-09-07 香港中文大学 检测dna甲基化程度的方法和试剂盒
US10179937B2 (en) * 2014-04-21 2019-01-15 Natera, Inc. Detecting mutations and ploidy in chromosomal segments
US9892230B2 (en) 2012-03-08 2018-02-13 The Chinese University Of Hong Kong Size-based analysis of fetal or tumor DNA fraction in plasma
US10706957B2 (en) 2012-09-20 2020-07-07 The Chinese University Of Hong Kong Non-invasive determination of methylome of tumor from plasma
HRP20241142T1 (hr) 2012-09-20 2024-11-22 The Chinese University Of Hong Kong Neinvazivno određivanje metiloma tumora iz plazme
US9732390B2 (en) 2012-09-20 2017-08-15 The Chinese University Of Hong Kong Non-invasive determination of methylome of fetus or tumor from plasma
US20130309666A1 (en) 2013-01-25 2013-11-21 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
ES2685893T3 (es) * 2013-07-30 2018-10-15 Bgi Genomics Co., Limited Método para determinar la composición de ácidos nucleicos de una mezcla de ácidos nucleicos
US10174375B2 (en) * 2013-09-20 2019-01-08 The Chinese University Of Hong Kong Sequencing analysis of circulating DNA to detect and monitor autoimmune diseases
WO2015126840A1 (en) * 2014-02-18 2015-08-27 Bionano Genomics, Inc. Improved methods of determining nucleic acid structural information
US12492429B2 (en) 2014-04-21 2025-12-09 Natera, Inc. Detecting mutations and ploidy in chromosomal segments
AU2015257654A1 (en) 2014-05-09 2016-11-10 Lifecodexx Ag Detection of DNA that originates from a specific cell-type and related methods
EP2942400A1 (en) 2014-05-09 2015-11-11 Lifecodexx AG Multiplex detection of DNA that originates from a specific cell-type
WO2016010401A1 (ko) * 2014-07-18 2016-01-21 에스케이텔레콘 주식회사 산모의 혈청 dna를 이용한 태아의 단일유전자 유전변이의 예측방법
ES2890136T3 (es) * 2014-07-18 2022-01-17 Univ Hong Kong Chinese Análisis de patrones de metilación de tejidos en una mezcla de ADN
US20170211143A1 (en) 2014-07-25 2017-07-27 University Of Washington Methods of determining tissues and/or cell types giving rise to cell-free dna, and methods of identifying a disease or disorder using same
EP3766986B1 (en) * 2014-12-31 2022-06-01 Guardant Health, Inc. Detection and treatment of disease exhibiting disease cell heterogeneity and systems and methods for communicating test results
US10364467B2 (en) * 2015-01-13 2019-07-30 The Chinese University Of Hong Kong Using size and number aberrations in plasma DNA for detecting cancer
WO2016127944A1 (en) * 2015-02-10 2016-08-18 The Chinese University Of Hong Kong Detecting mutations for cancer screening and fetal analysis
WO2017012544A1 (en) 2015-07-20 2017-01-26 The Chinese University Of Hong Kong Methylation pattern analysis of haplotypes in tissues in dna mixture
EP3967775B1 (en) * 2015-07-23 2023-08-23 The Chinese University Of Hong Kong Analysis of fragmentation patterns of cell-free dna
EP3334843A4 (en) 2015-08-12 2019-01-02 The Chinese University Of Hong Kong Single-molecule sequencing of plasma dna
TWI858334B (zh) 2015-09-22 2024-10-11 香港中文大學 藉由母體血漿ｄｎａ之淺深度測序以準確定量胎兒dna含量
US10260088B2 (en) * 2015-10-30 2019-04-16 New England Biolabs, Inc. Compositions and methods for analyzing modified nucleotides
EP3374521B1 (en) * 2015-11-09 2023-01-04 Biora Therapeutics, Inc. Methods for determining the origin of dna molecules
HUE050491T2 (hu) 2015-11-10 2020-12-28 Eurofins Lifecodexx Gmbh Magzati kromoszomális aneuploidiák kimutatása olyan DNS régiókat alkalmazva, amelyek különbözõképpen vannak metilezve a magzat és a terhes nõstény között
US11319593B2 (en) 2015-12-17 2022-05-03 Illumina, Inc. Distinguishing methylation levels in complex biological samples
US11335463B2 (en) * 2016-02-02 2022-05-17 Guardant Health, Inc. Cancer evolution detection and diagnostic
US11514289B1 (en) 2016-03-09 2022-11-29 Freenome Holdings, Inc. Generating machine learning models using genetic data
BR112018072536A2 (pt) 2016-05-03 2019-03-26 University Health Network métodos de captura de dna metilatado de célula livre e usos dos mesmos
US12300356B2 (en) 2016-05-04 2025-05-13 Queen's University At Kingston Cell-free detection of methylated tumour DNA
DK3464637T3 (da) 2016-05-30 2021-07-26 Univ Hong Kong Chinese Detektering af hæmatologiske forstyrrelser ved hjælp af cellefrit DNA i blod
EP3472358B1 (en) * 2016-06-16 2021-08-18 The Johns Hopkins University Methods and system for epigenetic analysis
WO2018036537A1 (zh) * 2016-08-24 2018-03-01 中国科学院上海生命科学研究院 Cmd1酶催化的5-甲基胞嘧啶核酸的新修饰及其应用
EP3529377B1 (en) * 2016-10-19 2023-04-05 The Chinese University Of Hong Kong Gestational age assessment by methylation and size profiling of maternal plasma dna
CN110100013A (zh) 2016-10-24 2019-08-06 香港中文大学 用于肿瘤检测的方法和系统
US11435339B2 (en) * 2016-11-30 2022-09-06 The Chinese University Of Hong Kong Analysis of cell-free DNA in urine
US20190309374A1 (en) * 2016-12-13 2019-10-10 Bellwether Bio, Inc. Determining a physiological condition in an individual by analyzing cell-free dna fragment endpoints in a biological sample
WO2018132400A1 (en) * 2017-01-11 2018-07-19 Quest Diagnostics Investments Llc Method for non-invasive prenatal screening for aneuploidy
RS65618B1 (sr) * 2017-01-24 2024-07-31 Bgi Genomics Co Ltd Postupak za utvrđivanje frakcije nukleinskih kiselina bez ćelija iz prethodno određenog izvora u biološkom uzorku
US10633713B2 (en) 2017-01-25 2020-04-28 The Chinese University Of Hong Kong Diagnostic applications using nucleic acid fragments
CN107247873B (zh) * 2017-03-29 2020-04-14 电子科技大学 一种差异甲基化位点识别方法
JP7368235B2 (ja) * 2017-05-12 2023-10-24 プレジデント アンド フェローズ オブ ハーバード カレッジ ユニバーサル早期がん診断
AU2018300157A1 (en) * 2017-07-12 2020-02-27 Ande Corporation Pattern recognition system
US12227737B2 (en) 2017-07-12 2025-02-18 University Health Network Cancer detection and classification using methylome analysis
US12031184B2 (en) 2017-07-12 2024-07-09 University Health Network Cancer detection and classification using methylome analysis
IL272030B2 (en) * 2017-07-26 2025-03-01 Univ Hong Kong Chinese Enhancement of cancer screening using cell-free viral nucleic acids
US20200263170A1 (en) 2017-09-14 2020-08-20 Grail, Inc. Methods for preparing a sequencing library from single-stranded dna
US11851650B2 (en) 2017-09-28 2023-12-26 Grail, Llc Enrichment of short nucleic acid fragments in sequencing library preparation
US11168356B2 (en) * 2017-11-02 2021-11-09 The Chinese University Of Hong Kong Using nucleic acid size range for noninvasive cancer detection
EP3765637A1 (en) 2018-03-13 2021-01-20 Grail, Inc. Anomalous fragment detection and classification
EP3766076A4 (en) 2018-03-15 2021-12-29 Grail, Inc. Tissue-specific methylation marker
EP3775198A4 (en) 2018-04-02 2022-01-05 Grail, Inc. METHYLATION MARKERS AND TARGETED METHYLATION PROBE PANELS
US11681953B2 (en) * 2018-04-13 2023-06-20 Freenome Holdings, Inc. Machine learning implementation for multi-analyte assay development and testing
US20210104297A1 (en) * 2018-04-16 2021-04-08 Grail, Inc. Systems and methods for determining tumor fraction in cell-free nucleic acid
WO2019209884A1 (en) 2018-04-23 2019-10-31 Grail, Inc. Methods and systems for screening for conditions
US11932899B2 (en) * 2018-06-07 2024-03-19 10X Genomics, Inc. Methods and systems for characterizing nucleic acid molecules
CN109448789A (zh) * 2018-09-17 2019-03-08 上海派森诺生物科技股份有限公司 一种基于perl语言的种群特异SNP位点的自动化分析方法
EP3856903A4 (en) 2018-09-27 2022-07-27 Grail, LLC METHYLATION MARKER AND TARGETED METHYLATION PROBE PANEL
CN109295230A (zh) * 2018-10-24 2019-02-01 福建翊善生物科技有限公司 一种基于ctDNA的多基因联合突变检测评估肿瘤动态变化的方法
GB2615955B (en) 2018-11-21 2023-11-22 Agilent Technologies Inc Methods for targeted nucleic acid library formation
SG11202106114XA (en) * 2018-12-19 2021-07-29 Univ Hong Kong Chinese Cell-free dna end characteristics
US12234514B2 (en) 2018-12-21 2025-02-25 Grail, Inc. Source of origin deconvolution based on methylation fragments in cell-free DNA samples
EP3921445B1 (en) 2019-02-05 2024-09-04 Grail, Inc. Detecting cancer, cancer tissue of origin, and/or a cancer cell type
WO2020163410A1 (en) 2019-02-05 2020-08-13 Grail, Inc. Detecting cancer, cancer tissue of origin, and/or a cancer cell type
AU2020246747A1 (en) 2019-03-25 2021-08-26 Grail, Inc. Determining linear and circular forms of circulating nucleic acids
US11773450B2 (en) 2019-04-03 2023-10-03 Grail, Llc Methylation-based false positive duplicate marking reduction
SG11202112246UA (en) * 2019-05-03 2021-12-30 Univ Cornell Markers for identifying and quantifying of nucleic acid sequence mutation, expression, splice variant, translocation, copy number, or methylation changes
WO2021034034A1 (ko) * 2019-08-19 2021-02-25 주식회사 녹십자지놈 핵산 단편간 거리 정보를 이용한 염색체 이상 검출 방법
KR102452413B1 (ko) * 2019-08-19 2022-10-11 주식회사 지씨지놈 핵산 단편간 거리 정보를 이용한 염색체 이상 검출 방법
GB201915469D0 (en) 2019-10-24 2019-12-11 Univ London Cancer detection methods
CN115836349A (zh) * 2019-11-27 2023-03-21 格里尔公司 用于评估纵向生物特征数据的系统和方法
JP7732991B2 (ja) 2020-01-31 2025-09-02 アジレント・テクノロジーズ・インク 標的化された核酸捕捉のためのシステムおよび方法
EP4103740A1 (en) * 2020-02-10 2022-12-21 Palogen, Inc. Nanopore device and methods of detecting and classifying charged particles using same
US11475981B2 (en) 2020-02-18 2022-10-18 Tempus Labs, Inc. Methods and systems for dynamic variant thresholding in a liquid biopsy assay
US11211147B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing
US11211144B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Methods and systems for refining copy number variation in a liquid biopsy assay
AU2021228737A1 (en) * 2020-02-28 2022-09-22 Grail, LLC. Identifying methylation patterns that discriminate or indicate a cancer condition
CN112662764A (zh) * 2020-03-17 2021-04-16 博尔诚（北京）科技有限公司 一种检测11种癌症的探针组合物
RU2738675C1 (ru) * 2020-07-28 2020-12-15 Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ прогнозирования риска развития преэклампсии у женщин без отягощенного семейного анамнеза с учетом генетических факторов
CN116848262A (zh) * 2020-11-19 2023-10-03 纽克莱克斯有限公司 使用限制性酶和高通量测序检测dna样品中的甲基化改变
JP2024500872A (ja) * 2020-12-17 2024-01-10 プレジデント アンド フェローズ オブ ハーバード カレッジ 胚外メチル化ＣｐＧアイランドを用いたがん検出の方法
CN112813148A (zh) * 2021-02-02 2021-05-18 博淼生物科技（北京）有限公司 飞行时间质谱检测5-羟甲基胞嘧啶的方法
CN118302816A (zh) * 2021-09-28 2024-07-05 行动基因(智财)有限公司 甲基化生物标记选择装置及方法
KR20230059423A (ko) * 2021-10-26 2023-05-03 주식회사 지씨지놈 메틸화된 무세포 핵산을 이용한 암 진단 및 암 종 예측방법
WO2023079047A1 (en) * 2021-11-04 2023-05-11 Universal Diagnostics S.A Systems and methods for preparing biological samples for genetic sequencing
EP4476358A4 (en) 2022-02-07 2025-07-16 Centre For Novostics FRAGMENTATION TO MEASURE METHYLATION AND DISEASE
US20240150840A1 (en) * 2022-02-22 2024-05-09 Flagship Pioneering Innovations Vi, Llc Intra-individual analysis for presence of health conditions
CN115064211B (zh) * 2022-08-15 2023-01-24 臻和(北京)生物科技有限公司 一种基于全基因组甲基化测序的ctDNA预测方法及装置
CN115612723B (zh) * 2022-09-26 2023-07-14 广州女娲生命科技有限公司 植入前胚胎的筛选方法
WO2024203348A1 (ja) * 2023-03-31 2024-10-03 ソニーグループ株式会社 腫瘍の解析方法、腫瘍の解析システム、及び腫瘍の解析データ生成方法
CN118737268A (zh) * 2023-05-04 2024-10-01 杭州圣庭医疗科技有限公司 一种鉴定肿瘤组织来源的试剂盒的数据分析方法
CN117025753A (zh) * 2023-08-15 2023-11-10 广州女娲生命科技有限公司 检测染色体变异的方法和装置
CN117079822B (zh) * 2023-10-17 2024-01-02 北京大学第三医院（北京大学第三临床医学院） 一种妊娠早中期四因子预测胎儿脑损伤的系统

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6927028B2 (en) 2001-08-31 2005-08-09 Chinese University Of Hong Kong Non-invasive methods for detecting non-host DNA in a host using epigenetic differences between the host and non-host DNA
DE60207979T2 (de) † 2002-03-05 2006-09-28 Epigenomics Ag Verfahren und Vorrichtung zur Bestimmung der Gewebespezifität von freier DNA in Körperflüssigkeiten
PL376971A1 (pl) † 2002-11-19 2006-01-23 Amgen, Inc. Amplifikowane geny związane z rakiem
US20060183128A1 (en) † 2003-08-12 2006-08-17 Epigenomics Ag Methods and compositions for differentiating tissues for cell types using epigenetic markers
DE10348407A1 (de) 2003-10-17 2005-05-19 Widschwendter, Martin, Prof. Prognostische und diagnostische Marker für Zell-proliferative Erkrankungen von Brustgeweben
CA2902980A1 (en) * 2004-03-08 2005-09-29 Rubicon Genomics, Inc. Methods and compositions for generating and amplifying dna libraries for sensitive detection and analysis of dna methylation
JP2008545418A (ja) 2005-05-27 2008-12-18 ジョン ウェイン キャンサー インスティチュート 癌の診断、予後診断、および治療のための遊離循環ｄｎａの使用
US7901884B2 (en) * 2006-05-03 2011-03-08 The Chinese University Of Hong Kong Markers for prenatal diagnosis and monitoring
US7754428B2 (en) 2006-05-03 2010-07-13 The Chinese University Of Hong Kong Fetal methylation markers
CN101153336B (zh) * 2006-09-27 2011-09-07 香港中文大学 检测dna甲基化程度的方法和试剂盒
EP2173897A2 (en) 2007-06-19 2010-04-14 Oncomethylome Sciences SA Improved urine sample collecting and processing
CA3076142C (en) 2007-07-23 2023-01-03 The Chinese University Of Hong Kong Analyzing tumor dna in a cell-free sample
JP4347372B2 (ja) 2007-08-10 2009-10-21 トヨタ自動車株式会社 静電塗装装置
US20110028333A1 (en) * 2009-05-01 2011-02-03 Brown University Diagnosing, prognosing, and early detection of cancers by dna methylation profiling
US8563242B2 (en) * 2009-08-11 2013-10-22 The Chinese University Of Hong Kong Method for detecting chromosomal aneuploidy
CA2775671A1 (en) * 2009-10-02 2011-04-07 Centre For Addiction And Mental Health Method for analysis of dna methylation profiles of cell-free circulating dna in bodily fluids
MX2012005214A (es) * 2009-11-05 2012-09-21 Sequenom Inc Analisis genomico fetal de muestra biologica materna.
AU2010317019B2 (en) 2009-11-06 2014-10-30 The Chinese University Of Hong Kong Size-based genomic analysis
CA2786564A1 (en) * 2010-01-19 2011-07-28 Verinata Health, Inc. Identification of polymorphic sequences in mixtures of genomic dna by whole genome sequencing
EA023565B1 (ru) * 2010-01-26 2016-06-30 ЭнАйПиДи ДЖЕНЕТИКС ЛТД. Способы и композиции для неинвазивной пренатальной диагностики анеуплоидии плода
AU2011249015B2 (en) † 2010-04-29 2016-05-26 The Regents Of The University Of California Pathway recognition algorithm using data integration on genomic models (PARADIGM)
GB201007944D0 (en) * 2010-05-12 2010-06-30 Univ Aberystwyth Methods
DK2576832T3 (en) 2010-05-25 2016-06-20 Univ Johns Hopkins CONFIGURATIONS AND METHODS FOR DETECTION OF neoplasia
CN103069006A (zh) * 2010-07-23 2013-04-24 艾索特里克斯遗传实验室有限责任公司 区别表达的胚胎或母源基因组区的鉴定及其用途
EP2596132A4 (en) * 2010-07-23 2013-12-18 Harvard College METHOD FOR DETECTING SIGNS FOR ILLNESS OR SUFFERING IN BODY FLUIDS
WO2012031329A1 (en) * 2010-09-10 2012-03-15 Murdoch Childrens Research Institute Assay for detection and monitoring of cancer
TWI786520B (zh) † 2010-11-30 2022-12-11 香港中文大學 與癌症有關之基因或分子變異之檢測
HRP20241142T1 (hr) * 2012-09-20 2024-11-22 The Chinese University Of Hong Kong Neinvazivno određivanje metiloma tumora iz plazme

Also Published As

Publication number Publication date
JP2022031753A (ja) 2022-02-22
DK4056712T3 (da) 2024-08-26
TW202043483A (zh) 2020-12-01
NZ706269A (en) 2016-08-26
HRP20241142T1 (hr) 2024-11-22
MX2015003571A (es) 2015-06-22
LT4056712T (lt) 2024-09-10
ES2862726T3 (es) 2021-10-07
AU2020200128A1 (en) 2020-01-30
NZ717423A (en) 2017-08-25
EP3354747B1 (en) 2021-02-17
EP3536807B1 (en) 2023-11-29
EP4056712A1 (en) 2022-09-14
KR102390711B1 (ko) 2022-04-26
PT4056712T (pt) 2024-08-08
PL3354747T3 (pl) 2021-07-26
CA2884066C (en) 2021-08-10
JP2020108400A (ja) 2020-07-16
AU2013317708A1 (en) 2015-04-09
EA201500327A1 (ru) 2015-07-30
CY1124139T1 (el) 2022-05-27
HUE068129T2 (hu) 2024-12-28
DK3354747T3 (da) 2021-04-19
BR122021021823B1 (pt) 2023-04-25
DK3536807T3 (da) 2024-02-05
HK1257868A1 (en) 2019-11-01
AU2017251832A1 (en) 2017-11-16
SG10201705198UA (en) 2017-07-28
CN104781422B (zh) 2023-12-26
PH12022552061A1 (en) 2024-03-11
PT3354747T (pt) 2021-05-07
AU2013317708C1 (en) 2017-11-23
TWI640634B (zh) 2018-11-11
KR102307424B1 (ko) 2021-09-29
PH12015500547B1 (en) 2024-05-17
ZA201501772B (en) 2016-10-26
EP3839065A1 (en) 2021-06-23
KR20230145530A (ko) 2023-10-17
EP2898100B2 (en) 2023-05-10
TWI784258B (zh) 2022-11-21
KR20210120124A (ko) 2021-10-06
BR122021021825B1 (pt) 2022-05-24
TWI806621B (zh) 2023-06-21
PH12015500547A1 (en) 2015-05-04
AU2022201026A1 (en) 2022-03-10
IL299444A (en) 2023-02-01
TWI707953B (zh) 2020-10-21
HK1206797A1 (en) 2016-01-15
ES2994426T3 (en) 2025-01-23
TW201907013A (zh) 2019-02-16
EP3354747A1 (en) 2018-08-01
HRP20210716T1 (hr) 2021-06-11
FI4056712T3 (fi) 2024-08-29
PT3536807T (pt) 2024-02-01
JP2015536639A (ja) 2015-12-24
PL3536807T3 (pl) 2024-05-06
ES2969567T3 (es) 2024-05-21
IL313451A (en) 2024-08-01
JP2024009833A (ja) 2024-01-23
PL4056712T3 (pl) 2024-12-02
EP4335929B1 (en) 2026-01-21
LT3354747T (lt) 2021-04-12
AU2022201026B2 (en) 2025-04-03
JP7594817B2 (ja) 2024-12-05
JP6683752B2 (ja) 2020-04-22
HRP20240210T1 (hr) 2024-05-10
EP4335929A3 (en) 2024-05-29
BR112015006183A2 (pt) 2017-07-04
HK1207124A1 (en) 2016-01-22
AU2025205087A1 (en) 2025-07-24
EP2898100A4 (en) 2016-05-11
EP2898100B1 (en) 2017-11-22
SMT202100256T1 (it) 2021-05-07
AU2017251832B2 (en) 2019-10-10
CN104781422A (zh) 2015-07-15
SG11201501927VA (en) 2015-04-29
CA3122779A1 (en) 2014-03-27
IL237495A0 (en) 2015-04-30
MY173356A (en) 2020-01-21
MX360034B (es) 2018-10-19
ES2665273T3 (es) 2018-04-25
PT2898100T (pt) 2018-02-26
KR20200085928A (ko) 2020-07-15
KR102148547B1 (ko) 2020-08-26
IL268512A (en) 2019-09-26
EP4056712B1 (en) 2024-07-31
EP2898100B9 (en) 2023-08-02
JP2018121644A (ja) 2018-08-09
IL299444B1 (en) 2024-07-01
KR20220065034A (ko) 2022-05-19
CA2884066A1 (en) 2014-03-27
CN117757932A (zh) 2024-03-26
AU2013317708B2 (en) 2017-08-03
TW202305145A (zh) 2023-02-01
TWI901957B (zh) 2025-10-21
IL268512B2 (en) 2023-06-01
TW201418474A (zh) 2014-05-16
JP6985753B2 (ja) 2021-12-22
WO2014043763A1 (en) 2014-03-27
EP3536807A1 (en) 2019-09-11
ES2665273T5 (es) 2023-10-02
HUE053822T2 (hu) 2021-07-28
EP2898100A1 (en) 2015-07-29
FI3536807T3 (fi) 2024-02-01
EP4335929A2 (en) 2024-03-13
BR112015006183B1 (pt) 2022-04-26
PL2898100T3 (pl) 2018-06-29
DK2898100T3 (en) 2018-02-26
IL299444B2 (en) 2024-11-01
AU2020200128B2 (en) 2021-11-18
MY187444A (en) 2021-09-22
KR102587176B1 (ko) 2023-10-06
IL237495B (en) 2019-09-26
DK2898100T4 (da) 2023-07-24
SI4056712T1 (sl) 2024-10-30
HUE066054T2 (hu) 2024-07-28
PL2898100T5 (pl) 2023-11-06
JP2025026936A (ja) 2025-02-26
KR20150082228A (ko) 2015-07-15
TW202334438A (zh) 2023-09-01

Similar Documents

Publication Publication Date Title
JP7594817B2 (ja) 血漿による胎児または腫瘍のメチロームの非侵襲的決定
US20250349386A1 (en) Non-invasive detection of tissue abnormality using methylation
HK40055436A (en) Non-invasive determination of methylome of tumor from plasma
HK40013800B (en) Non-invasive determination of methylome of tumor from plasma
EA042157B1 (ru) Неинвазивное определение метилома плода или опухоли по плазме
HK1207124B (zh) 从血浆无创测定胎儿或肿瘤的甲基化组
HK1206797B (en) Non-invasive determination of methylome of fetus or tumor from plasma

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160706

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160706

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170516

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20170815

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20171116

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180227

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20180329

R150 Certificate of patent or registration of utility model

Ref document number: 6317354

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250